Lv6
3130 积分 2022-10-27 加入
Patient-Reported Meaningful Change in Symptoms and Impacts of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Three Phase III Clinical Trials of Iptacopan
13小时前
待确认
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
13小时前
已完结
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
28天前
已关闭
POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL
2个月前
已关闭
Enhancing Hidradenitis Suppurativa Assessment
2个月前
已完结
Contraception Requirements in Early Clinical Trials: Considerations Towards an Evidence-Based Approach
2个月前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
2个月前
已完结
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
2个月前
已完结
Intra-rater agreement of lesion counts in hidradenitis suppurativa
2个月前
已关闭
Photographic Assessment of the Anatomic Localization and Extent of Hidradenitis Suppurativa: A Delphi Study
3个月前
已完结
皖公网安备34019202002308
